Correlation Between Ikena Oncology and Instil Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Instil Bio, you can compare the effects of market volatilities on Ikena Oncology and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Instil Bio.

Diversification Opportunities for Ikena Oncology and Instil Bio

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Ikena and Instil is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Instil Bio go up and down completely randomly.

Pair Corralation between Ikena Oncology and Instil Bio

Given the investment horizon of 90 days Ikena Oncology is expected to under-perform the Instil Bio. But the stock apears to be less risky and, when comparing its historical volatility, Ikena Oncology is 11.22 times less risky than Instil Bio. The stock trades about -0.08 of its potential returns per unit of risk. The Instil Bio is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  1,323  in Instil Bio on August 25, 2024 and sell it today you would earn a total of  1,292  from holding Instil Bio or generate 97.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ikena Oncology  vs.  Instil Bio

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Instil Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

Ikena Oncology and Instil Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and Instil Bio

The main advantage of trading using opposite Ikena Oncology and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.
The idea behind Ikena Oncology and Instil Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences